Board Member
Design Therapeutics, Inc. (DSGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Design Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DSGN alertsPratik Shah is recorded as Board Member at Design Therapeutics, Inc. (DSGN) since January 1, 2017 and CEO at Design Therapeutics, Inc. (DSGN). The newest filing on record that lists Pratik Shah as CEO and Board Member at Design Therapeutics, Inc. (DSGN) is dated April 23, 2026. The proxy statement of Design Therapeutics, Inc. reports total compensation of $3,544,300 for Pratik Shah in fiscal 2025, including a base salary of $395,000. Disclosed compensation is on record for 6 fiscal years. Pratik Shah has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Design Therapeutics, Inc. on June 4, 2026. Design Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Design Therapeutics, Inc. includes Pratik Shah, Ph.D. (CEO), Sean Jeffries (COO), Dawn Giangiulio (Chief Accounting Officer) and 7 others.
“Design is developing a new class of small-molecule genomic medicines. where we have a very unique approach, which is to have molecules that can recognize specific DNA sequences and by doing so can dial up or down individual genes in the genome.”
“On behalf of Design Therapeutics, I am delighted to announce an earlier than anticipated readout on our Restore FA study, a multiple ascending dose study in patients with Friedrich ataxia.”
“I'm excited to present Design Therapeutics’ First Significant Update for 2024. What makes this company unique and compelling is that we have discovered a new class of small molecules that are designed to dial up or dial down the expression of an individual gene in the genome.”
2017-01-01–present
Last confirmed April 23, 2026
Start not stated–present
Last confirmed April 23, 2026
Proxy statement
Start not stated–2023-04-13
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Design Therapeutics, Inc. (DSGN) | President, Chief Executive Officer and Chairperson | $395,000 | $3,544,300 |
| 2024 | Design Therapeutics, Inc. (DSGN) | President, Chief Executive Officer and Chairperson | $395,000 | $789,800 |
| 2023 | Design Therapeutics, Inc. (DSGN) | President, Chief Executive Officer and Chairperson | $360,600 | $6,317,780 |
| 2022 | Design Therapeutics, Inc. (DSGN) | President, Chief Executive Officer and Chairperson | $337,510 | $4,515,565 |
| 2021 | Design Therapeutics, Inc. (DSGN) | Executive Chairperson | $310,030 | $585,030 |
| 2020 | Design Therapeutics, Inc. (DSGN) | Executive Chairperson | $250,000 | $400,000 |
